BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16773185)

  • 21. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.
    Andersson A; Edén P; Olofsson T; Fioretos T
    BMC Med Genomics; 2010 Mar; 3():6. PubMed ID: 20211010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias.
    Balcerczak E; Bartkowiak J; Błoński JZ; Robak T; Mirowski M
    Neoplasma; 2002; 49(5):295-9. PubMed ID: 12458326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.
    D'ambrosio C; Akin C; Wu Y; Magnusson MK; Metcalfe DD
    J Allergy Clin Immunol; 2003 Dec; 112(6):1162-70. PubMed ID: 14657877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
    Zucchetto A; Sonego P; Degan M; Bomben R; Dal Bo M; Russo S; Attadia V; Rupolo M; Buccisano F; Steffan A; Del Poeta G; Pucillo C; Colombatti A; Campanini R; Gattei V
    J Immunol Methods; 2005 Oct; 305(1):20-32. PubMed ID: 16198366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
    Willman CL
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal approach for classification of acute leukemia subtypes based on gene expression data.
    Cho JH; Lee D; Park JH; Kim K; Lee IB
    Biotechnol Prog; 2002; 18(4):847-54. PubMed ID: 12153320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evolution of gene expression profile in 3 cases of acute myeloid leukemia].
    Tang JM; Meng FY; Ma WL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):653-5. PubMed ID: 16620549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetics in acute leukemia.
    Mrózek K; Heerema NA; Bloomfield CD
    Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
    Downing JR
    Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
    Heuser M; Wingen LU; Steinemann D; Cario G; von Neuhoff N; Tauscher M; Bullinger L; Krauter J; Heil G; Döhner H; Schlegelberger B; Ganser A
    Haematologica; 2005 Nov; 90(11):1484-92. PubMed ID: 16266895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Bacher U; Kohlmann A; Haferlach T
    Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Buldini B; Zangrando A; Michielotto B; Veltroni M; Giarin E; Tosato F; Cazzaniga G; Biondi A; Basso G
    Am J Hematol; 2010 Feb; 85(2):138-41. PubMed ID: 20095033
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of murine gene expression profiles between spontaneous and radiation-induced myelogenous leukemias: stochastic and probabilistic expression variances in the former vs radiation-specific expression commonalities in the latter.
    Hirabayashi Y; Tsuboi I; Kitada K; Igarashi K; Kodama Y; Kanno J; Yoshida K; Dainiak N; Inoue T
    Exp Hematol; 2009 Feb; 37(2):195-205. PubMed ID: 19070417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profile related to prognosis of acute myeloid leukemia.
    Park MH; Cho SA; Yoo KH; Yang MH; Ahn JY; Lee HS; Lee KE; Mun YC; Cho DH; Seong CM; Park JH
    Oncol Rep; 2007 Dec; 18(6):1395-402. PubMed ID: 17982622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
    Rouer E; Dreyfus F; Melle J; Benarous R
    Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
    Bresolin S; Zecca M; Flotho C; Trentin L; Zangrando A; Sainati L; Stary J; de Moerloose B; Hasle H; Niemeyer CM; Te Kronnie G; Locatelli F; Basso G
    J Clin Oncol; 2010 Apr; 28(11):1919-27. PubMed ID: 20231685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.